Rising Pharma cyproheptadine syrup recalled for precipitate
Rising Pharma's Cyproheptadine Hydrochloride Syrup (2 mg/5 mL, 473 mL bottles) is being recalled because the medication is crystallizing and forming particles that float in the bottle. This affects specific batches distributed nationwide. No injuries have been reported.
From the FDA notice · Read the official notice ↗
What to do
- Check if you have an affected batch (CR2518, CR2601, CR2602, CR2603, CR2604, or CR2605).
- Do not use medication from affected batches.
- Contact your pharmacist or prescriber for a replacement or alternative medication.
Is yours affected?
Compare your label or packaging with the recalled product.
- Product
- Rising, Cyproheptadine Hydrochloride Syrup, 2mg/5 mL, 473 mL (ONE PINT), Rx only, Manufactured for: Rising Pharma Holdings, Inc., East Brunswick, NJ, Manufactured by: Lyne Laboratories, Inc., Brockton, MA. NDC 64980-504-48.
- Sold in
- Nationwide
- Made for
- All ages (0 months and older)
Details
- Units affected
- 74208 units
- Illnesses reported
- None reported
- Manufactured in
- 2 Tower Center Blvd Ste 1401, N/A, East Brunswick, NJ, United States
- Classification
- Class II
- Recall number
- D-0724-2026
In the FDA's words
- Description
- Rising, Cyproheptadine Hydrochloride Syrup, 2mg/5 mL, 473 mL (ONE PINT), Rx only, Manufactured for: Rising Pharma Holdings, Inc., East Brunswick, NJ, Manufactured by: Lyne Laboratories, Inc., Brockton, MA. NDC 64980-504-48. Presence of Precipitate: medication was crystallizing and particles floating in the bottle Lots: Batch # CR2518, Exp. 11/2027; Batch # CR2601, Exp. 12/2027; CR2602, CR2603, Exp. 01/2028; CR2604, CR2605, Exp. 02/2028. Distribution: Nationwide U.S.A. Affected quantity: 74208 units
- Hazard
- Presence of Precipitate: medication was crystallizing and particles floating in the bottle